ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 251 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,900 | -3.8% | 10,000 | -0.1% | 0.02% | -5.3% |
| Q2 2023 | $183,957 | -2.6% | 10,014 | 0.0% | 0.02% | -5.0% |
| Q1 2023 | $188,964 | +8.0% | 10,014 | 0.0% | 0.02% | +5.3% |
| Q4 2022 | $174,945 | +8.7% | 10,014 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $161,000 | -7.5% | 10,014 | 0.0% | 0.02% | -5.0% |
| Q2 2022 | $174,000 | -6.5% | 10,014 | 0.0% | 0.02% | +11.1% |
| Q1 2022 | $186,000 | +5.7% | 10,014 | 0.0% | 0.02% | +5.9% |
| Q4 2021 | $176,000 | -94.3% | 10,014 | -94.5% | 0.02% | -95.0% |
| Q3 2021 | $3,086,000 | -1.9% | 183,124 | -1.1% | 0.34% | -2.0% |
| Q2 2021 | $3,145,000 | +1.9% | 185,124 | -1.6% | 0.35% | -2.5% |
| Q1 2021 | $3,087,000 | -59.1% | 188,224 | -54.4% | 0.36% | -62.6% |
| Q4 2020 | $7,549,000 | -0.6% | 412,974 | -1.4% | 0.96% | -8.7% |
| Q3 2020 | $7,598,000 | +5.8% | 418,650 | -0.0% | 1.05% | +2.4% |
| Q2 2020 | $7,179,000 | – | 418,848 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prostatis Group LLC | 500,689 | $7,585,438 | 10.78% |
| Almanack Investment Partners, LLC. | 2,310,779 | $35,008,000 | 7.52% |
| Hudock, Inc. | 959,228 | $14,532,000 | 5.71% |
| SimpliFi, Inc. | 595,575 | $9,023,000 | 5.64% |
| UBP Investment Advisors SA | 405,987 | $6,151,000 | 5.56% |
| Allen Capital Group, LLC | 850,481 | $12,885,000 | 3.97% |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 84,266 | $1,276,000 | 2.98% |
| American Money Management, LLC | 302,921 | $4,589,000 | 2.57% |
| WT Wealth Management | 132,453 | $2,006,000 | 2.11% |
| FormulaFolio Investments, LLC | 2,385,654 | $36,143,000 | 1.93% |